Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A favorable follicular helper CD4+ T cell programming characterizes neutralization activity in chronic HIV infection
Eirini Moysi, Ashish A. Sharma, Sijy O’Dell, Spiros Georgakis, Perla Mariana Del Rio Estrada, Ghneim Khader, Alonso Arana, Fernanda Torres-Ruiz, Mauricio González Navarro, Yara Andrea Luna Villalobos, Santiago Avila Rios, Gustavo Reyes-Teran, Margaret H. Beddall, Sung Hee Ko, Frida Belinky, Michail Orfanakis, Laurence de Leval, Ana B. Enriquez, Clarisa M. Buckner, Susan Moir, Helen Lindsay, Raphael Gottardo, Nicole Doria-Rose, Eli A. Boritz, John R. Mascola, Rafick-Pierre Sekaly, Richard A. Koup, Constantinos Petrovas
Eirini Moysi, Ashish A. Sharma, Sijy O’Dell, Spiros Georgakis, Perla Mariana Del Rio Estrada, Ghneim Khader, Alonso Arana, Fernanda Torres-Ruiz, Mauricio González Navarro, Yara Andrea Luna Villalobos, Santiago Avila Rios, Gustavo Reyes-Teran, Margaret H. Beddall, Sung Hee Ko, Frida Belinky, Michail Orfanakis, Laurence de Leval, Ana B. Enriquez, Clarisa M. Buckner, Susan Moir, Helen Lindsay, Raphael Gottardo, Nicole Doria-Rose, Eli A. Boritz, John R. Mascola, Rafick-Pierre Sekaly, Richard A. Koup, Constantinos Petrovas
View: Text | PDF
Research Article AIDS/HIV Immunology

A favorable follicular helper CD4+ T cell programming characterizes neutralization activity in chronic HIV infection

  • Text
  • PDF
Abstract

A subset of people living with HIV (PLWH) can produce broadly neutralizing antibodies (bNAbs) against HIV, but the lymph node (LN) dynamics that promote the generation of these Abs are poorly understood. Here, we explored LN-associated histological, immunological, and virological determinants of bNAb generation in a cohort of antiretroviral therapy–naive PLWH. We found that participants who produce bNAbs, termed “neutralizers” (Ns), have a better-preserved LN-associated B cell follicle architecture than do PLWH who do not. The former was associated with a substantially higher in situ prevalence of B-cell lymphoma 6 (Bcl-6hi) follicular helper CD4+ T cells (Tfh), expressing a molecular program that favors their differentiation and stemness, and substantially reduced IL-10 follicular suppressor CD4+ T cells. Furthermore, our data reveal possible molecular targets mediating Tfh–B cell interactions in Ns. Together, we identify germinal center cellular and molecular signatures that could contribute to the development of bNAbs in PLWH.

Authors

Eirini Moysi, Ashish A. Sharma, Sijy O’Dell, Spiros Georgakis, Perla Mariana Del Rio Estrada, Ghneim Khader, Alonso Arana, Fernanda Torres-Ruiz, Mauricio González Navarro, Yara Andrea Luna Villalobos, Santiago Avila Rios, Gustavo Reyes-Teran, Margaret H. Beddall, Sung Hee Ko, Frida Belinky, Michail Orfanakis, Laurence de Leval, Ana B. Enriquez, Clarisa M. Buckner, Susan Moir, Helen Lindsay, Raphael Gottardo, Nicole Doria-Rose, Eli A. Boritz, John R. Mascola, Rafick-Pierre Sekaly, Richard A. Koup, Constantinos Petrovas

×

Figure 2

Cross-neutralization is associated with an expansion of the LN CD4+ T cell memory compartment and a distinct Tfh cell phenotypic profiling.

Options: View larger image (or click on image) Download as PowerPoint
Cross-neutralization is associated with an expansion of the LN CD4+ T ce...
(A) Flow cytometry plots depicting the frequencies of naive and non-naive CD4+ T cell subsets in NNs and Ns within the CD3hiCD4hi gated populations. (B) Graphs showing the relative frequencies of naive and non-naive CD4+ T cell subsets in Ns and NNs (left panel) and the positive association (Pearson correlation) between the percentage of non-naive CD27loCD45ROhi CD4+ T cells and microneutralization ID50 titers as assayed against a 20 HIV isolate panel. (C) Cumulative flow cytometry plots showing the frequencies of the receptors TIGIT and ICOS, as well as of the CD57 epitope and CXCR3 within the PD-1hiCXCR5hi Tfh cell compartment in NNs and Ns, and frequencies of combined CXCR3 and CD57 expression. TIGIT, P = 0.0075; ICOS, P = 0.0160; CD57; P = 0.0225; CXCR3, P = 0.0420 (Mann-Whitney U test); NN CXCR5loCD57hi versus NN CXCR3hiCD57lo, P < 0.0001 (1-way ANOVA). ****P < 0.0001. (D) Confocal images of follicles (CD20hi/dim) and GCs (CD20hiKi67hi) in NNs and N showing the distribution of CD4 (green), Tfh (CD4: green, PD-1hi: red) and Bcl-6+ Tfh (CD4: green, PD-1hi: red, Bcl-6hi: yellow) within the Ki67 follicular areas (magenta) and Superplots showing total GC-CD4, GC Bcl-6hi Tfh cell densities (cells per mm2) and GC Bcl-6hi Tfh/CD4 ratios of both individual (faint background symbols) and mean (bold foreground symbols) follicular measurements (± SEM) in NNs (n = 6 blue) versus Ns (n = 6 red) as measured by quantitative imaging analysis and histocytometry. Follicular area borders were determined based on the density of CD20 expression, whereas extrafollicular areas (T cell zone) were determined based on the density of CD4. Different symbols represent different donors. For statistical comparisons using the mean measurements, a Mann-Whitney U test was applied. P = 0.48; P = 0.132; P = 0.026. Original magnification, ×20. Scale bars: 60 μm left column; 30 μm right columns. (E) Regression plots showing the association between bulk Tfh and Bcl-6hi Tfh cells (normalized cell counts adjusted for mm2 of area screened) as quantified by confocal imaging analysis and histocytometry, and the breadth of neutralization expressed as the number of HIV isolates recognized among the 20 isolates tested. EF, extrafollicular area; F, follicular area. Mean ± SD values are shown in B and C and median values in D.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts